Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDIV × pembrolizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 249 OTHER 159 NIH 11 OTHER_GOV 2 NETWORK 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Cancer 1

Interventions

pembrolizumab 1 keyhole-limpet hemocyanin 1 Peptides 1 Monatide (IMS 3015) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Aptabio Therapeutics, Inc.

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡